AU2015208739B2 - Topical antibiotic formulations - Google Patents

Topical antibiotic formulations Download PDF

Info

Publication number
AU2015208739B2
AU2015208739B2 AU2015208739A AU2015208739A AU2015208739B2 AU 2015208739 B2 AU2015208739 B2 AU 2015208739B2 AU 2015208739 A AU2015208739 A AU 2015208739A AU 2015208739 A AU2015208739 A AU 2015208739A AU 2015208739 B2 AU2015208739 B2 AU 2015208739B2
Authority
AU
Australia
Prior art keywords
silver
formulation
carboxylate
aliphatic
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2015208739A
Other languages
English (en)
Other versions
AU2015208739A1 (en
Inventor
Elia ALTABET
Perry Antelman
Shalom Lampert
Bharat MADHAVAN
Joshua Steven STEIN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aidance Skincare and Topical Solutions LLC
Original Assignee
Aidance Skincare and Topical Solutions LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aidance Skincare and Topical Solutions LLC filed Critical Aidance Skincare and Topical Solutions LLC
Publication of AU2015208739A1 publication Critical patent/AU2015208739A1/en
Application granted granted Critical
Publication of AU2015208739B2 publication Critical patent/AU2015208739B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2015208739A 2014-01-27 2015-01-27 Topical antibiotic formulations Active AU2015208739B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461931944P 2014-01-27 2014-01-27
US61/931,944 2014-01-27
PCT/IB2015/050630 WO2015111032A1 (en) 2014-01-27 2015-01-27 Topical antibiotic formulations

Publications (2)

Publication Number Publication Date
AU2015208739A1 AU2015208739A1 (en) 2016-08-25
AU2015208739B2 true AU2015208739B2 (en) 2020-04-16

Family

ID=53680912

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2015208739A Active AU2015208739B2 (en) 2014-01-27 2015-01-27 Topical antibiotic formulations

Country Status (12)

Country Link
US (1) US9901541B2 (enExample)
EP (1) EP3099310B1 (enExample)
JP (1) JP6622218B2 (enExample)
KR (1) KR102292758B1 (enExample)
CN (1) CN106211756B (enExample)
AU (1) AU2015208739B2 (enExample)
CA (1) CA2974179C (enExample)
IL (1) IL246981B (enExample)
MX (1) MX383014B (enExample)
RU (1) RU2681544C2 (enExample)
WO (1) WO2015111032A1 (enExample)
ZA (1) ZA201605935B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10376541B2 (en) * 2014-01-27 2019-08-13 Aidance Skincare & Topical Solutions Llc Topical antibiotic formulations
ES2979247T3 (es) * 2017-04-07 2024-09-25 Univ Western Australia Un método para ensayar la sensibilidad a los antimicrobianos

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020127282A1 (en) * 1991-12-05 2002-09-12 N. Jonas & Co., Inc. A/K/A N. Jonas & Co. Multivalent silver pharmaceuticals

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728323A (en) 1986-07-24 1988-03-01 Minnesota Mining And Manufacturing Company Antimicrobial wound dressings
JPH03141205A (ja) * 1989-10-24 1991-06-17 Ajinomoto Co Inc 抗菌剤
US5491059A (en) * 1994-10-31 1996-02-13 Minnesota Mining And Manufacturing Company Silver carboxylate compounds as silver sources in photothermographic and thermographic elements
JPH0967231A (ja) * 1995-09-01 1997-03-11 Nikko Kemikaruzu Kk 脂肪酸銀を含有する抗菌剤組成物及び該脂肪酸銀を含有する化粧品
NZ512267A (en) * 1998-11-09 2003-11-28 Ira Jay Newman Ionic silver complex
US8283135B2 (en) * 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
US7001617B2 (en) * 2001-04-23 2006-02-21 Nueryst Pharmaceuticals Corp. Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals
JP4303915B2 (ja) * 2002-05-31 2009-07-29 山口 康子 抗菌性組成物及びその製造方法
US20050069502A1 (en) * 2003-08-15 2005-03-31 Chopra Suman K. Hydrophobic polymer carrier based liquid tooth whitening composition
CN102783499A (zh) * 2004-07-30 2012-11-21 金伯利-克拉克环球有限公司 抗微生物的装置和组合物
CN101336640A (zh) 2008-08-29 2009-01-07 宜兴市乔阳电器有限公司 四氧化四银杀菌剂、制备方法及其应用
GB2472126B (en) * 2009-07-21 2011-08-03 Aidance Skincare & Topical Solutions Llc Topical Formulations Containing Silver (II) Oxide and Zinc Oxide
FI20115692L (fi) * 2011-06-30 2012-12-31 Silverphase Oy Polymeerinen antimikrobinen lisäaine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020127282A1 (en) * 1991-12-05 2002-09-12 N. Jonas & Co., Inc. A/K/A N. Jonas & Co. Multivalent silver pharmaceuticals

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CARLA SPINA, PH.D. ET AL., SAWC, SPRING MEETING 2011, DALLAS, (2011-06-01), URL: HTTP://WWW.EXCITONTECH.COM/IMAGES/DOCS/EXSALT SCIENCE UNIQUE SILVER.PDF *
KAZACHENKO, A. ET AL., PHARMACEUTICAL CHEMISTRY JOURNAL (TRANSLATION OF KHIMIKO- FARMATSEVTICHESKII ZHURNAL, (20000531), vol. 34, no. 5, pages 257 - 258 *

Also Published As

Publication number Publication date
CA2974179C (en) 2022-06-21
US9901541B2 (en) 2018-02-27
EP3099310A4 (en) 2017-07-26
CA2974179A1 (en) 2015-07-30
MX383014B (es) 2025-03-12
WO2015111032A1 (en) 2015-07-30
AU2015208739A1 (en) 2016-08-25
CN106211756A (zh) 2016-12-07
KR20160112004A (ko) 2016-09-27
IL246981A0 (en) 2016-09-29
JP2017503864A (ja) 2017-02-02
KR102292758B1 (ko) 2021-08-24
EP3099310B1 (en) 2025-10-01
CN106211756B (zh) 2019-12-27
US20160184221A1 (en) 2016-06-30
RU2016134417A3 (enExample) 2018-09-20
ZA201605935B (en) 2017-11-29
IL246981B (en) 2021-02-28
MX2016009696A (es) 2017-03-27
JP6622218B2 (ja) 2019-12-18
RU2681544C2 (ru) 2019-03-11
RU2016134417A (ru) 2018-03-01
EP3099310A1 (en) 2016-12-07
EP3099310C0 (en) 2025-10-01

Similar Documents

Publication Publication Date Title
Rauf et al. Biomimetically synthesized ZnO nanoparticles attain potent antibacterial activity against less susceptible S. aureus skin infection in experimental animals
Zhang et al. Near-infrared-triggered antibacterial and antifungal photodynamic therapy based on lanthanide-doped upconversion nanoparticles
Ouyang et al. A black phosphorus based synergistic antibacterial platform against drug resistant bacteria
Javed et al. Effect of capping agents: structural, optical and biological properties of ZnO nanoparticles
Kim et al. Preparation and characterization of positively surface charged zinc oxide nanoparticles against bacterial pathogens
Veisi et al. Biosynthesis of the silver nanoparticles on the graphene oxide’s surface using Pistacia atlantica leaves extract and its antibacterial activity against some human pathogens
Hashemi et al. In-vitro anticancer and antibacterial activities and comparative of eco-friendly synthesized silver nanoparticles using hull of Pistacia vera and rhizome of Sambucus ebulus extracts
Yan et al. Preparation of graphene oxide/polydopamine-curcumin composite nanomaterials and its antibacterial effect against Staphylococcus aureus induced by white light
Kumari et al. Development and characterization of active poly (3-hydroxybutyrate) based composites with grapeseed oil and MgO nanoparticles for shelf-life extension of white button mushrooms (Agaricus bisporus)
AU2015208739B2 (en) Topical antibiotic formulations
Liao et al. Development of antibacterial and antifouling bio-based food packaging films using zwitterionic rosin-modified chitosan
US11013763B2 (en) Topical antibiotic formulations
Kasahun et al. Antimicrobial activity of chemical, thermal and green route-derived zinc oxide nanoparticles: a comparative analysis
Nagaiah et al. In vitro evaluation of silver-zinc oxide-eugenol nanocomposite for enhanced antimicrobial and wound healing applications in diabetic conditions
Nazeri et al. Er2TiO5@ Ag nanocomposites: enhanced photocatalysis and bacteria inactivation, and cytotoxicity
Nastulyavichus et al. Bactericidal impact of nickel-oxide nanoparticles on foodborne pathogens: Complementary microbiological and IR-spectroscopic insights
Pica et al. Antimicrobial performances of some film forming materials based on silver nanoparticles
Hussein et al. Evaluation of the synergistic effects of synthesized silver nanoparticles conjugated tetracycline
Chatterjee et al. Bacteria against bacteria: Green silver nanoparticle fabrication, antioxidant, anti-biofilm and antibacterial activities
Alfawadı et al. Evaluation of the Effect of the Size of Ramalina fraxinea Based Ag NPs on the Antimicrobial Activity
Khan et al. Biomimetically synthesized ZnO nanoparticles attain potentantibacterial activity against less susceptible S. aureus skin infection in experimental animals Mohd. Ahmar Rauf, Mohammad Owais1*, Ravikant Rajpoot2, Faraz Ahmad1
Hattab et al. Development of the Properties of Zinc Polycarboxylate Cement Used as a Basis for Dental Fillings Using Zink Oxide Nanoparticles Prepared by Green Chemistry Method
AU2021103328A4 (en) Synthesis and pharmacological evaluation of ibuprofen entrapped silver nanoparticles using herbals
Pawar et al. Biosynthesis of silver nanoparticles from banana peel extract and its antibacterial assay
Alsuwaidi et al. Antibacterial and Antibiofilm Efficacy of Green Synthesised Haloxylon Capped Silver Nanoparticles Against Enterococcus faecalis

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)